Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Physicians (Germany)

Council Members in this Study Group: 1172

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Volker Hoffmann, Partner/Owner, Diagnostic Imaging CenterVolker Hoffmann

Partner/Owner
Diagnostic Imaging Center
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Volker Hoffmann, MD, is a Diagnostic and Interventional Radiologist and one of the three owners of Diagnostic Imaging Center, a large private imaging center. <br/><br/>He was a Product Manager and Medical Consultant at Strategic Marketing of the Global...

3 news post(s)
Peter Rieckmann

Professor of Neurology and MS Research Chair
UNIVERSITY OF BRITISH COLUMBIA
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Peter Rieckmann, MD, FRCPC, is a Professor of Neurology and MS Research Chair at the University of British Columbia, Canada. He has established the Western Canadian MS Research and Training Center at UBC, Vancouver and is member of the EndMS steering...

Hossein Ghofrani, Physician, JUSTUS-LIEBIG-UNIVERSITAET GIESSENHossein Ghofrani

Physician
JUSTUS-LIEBIG-UNIVERSITAET GIESSEN
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Hossein Ardeschir (Ardi) Ghofrani, MD, is Lead physician of the Pulmonary Hypertension Centre at the University of Giessen Lung Center (UGLC), Germany. Prof. Ghofrani is a Reviewer for various high impact scientific journals including Lancet, AJRCCM,...

GLG NewsSM Analyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

NSF (Nephrogenic Systemic Fibrosis) - Gadoxetic Acid (Primovist)

October 9, 2007

Analysis by:Volker Hoffmann, Partner/Owner,

Study Finds NSF More Common Than Previously Reported | www.dimag.com

Nephrogenic systemic fibrosis is becoming a severe problem for radiologist and industry as it may prevent physicians from using gadolinium containing contrast agents fearing that they induce nephrogenic systemic fibrosis even in patients without known kidney disease. A stable contrast agent with almost no release of gadolinium may be a solution: gadoxetic acid, sold in Europe and Asia as Primovist.

IMDS - CTML - Value without contrast agents?

May 14, 2007

Analysis by:Volker Hoffmann, Partner/Owner,

Imaging Diagnostic Systems Breast Scanner Performance Upgrade Program Nearing Completion | www.medicalnewstoday.com

The recent upgrade of the Computed Tomography Laser Mammography (CTLM(R)) system will only added minor details. The question whether this system without any contrast agent is of any value has not been answered so far.

Impropved pancreatic duct imaging in MR - small market for Secretin

May 14, 2007

Analysis by:Volker Hoffmann, Partner/Owner,

Repligen Reports Positive Phase 2 Clinical Trial Results Of Secretin For MRI Imaging Of The Pancreas | www.medicalnewstoday.com

Pancreatic duct imaging is currently done with a heavily weighted T2 sequence that requires water in the duct for imaging. Increased production of pancreatic juice may make imaging easier. This is however a very small niche market which by itself will not allow survival of RG1068.

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Academic Institution*

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Physician - Division Head
  • Physician - Director
  • Physician - Department Chair
  • Owner
  • Director

Related Study Groups

Study Group Name No. Members
Oncologists in Germany 161
Oncologists (Germany, France, Italy) 343
Oncologists (EU) 761
Cardiologists (EU) 829
Neurologists (EU) 561
Neurologists 1861
Orthopedic Surgeons (EU) 380
Hematologists (EU) 358